N Wolmark Selected Research

Radiotherapy

8/2001	Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
1/2001	Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer.
3/2000	Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Wolmark Research Topics

Disease

13	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2000
12	Neoplasms (Cancer) 01/2021 - 01/2000
4	Colonic Neoplasms (Colon Cancer) 01/2020 - 02/2001
2	Noninfiltrating Intraductal Carcinoma (DCIS) 12/2001 - 08/2001
2	Aneuploidy (Aneuploid) 06/2001 - 01/2000
1	Triple Negative Breast Neoplasms 01/2022
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Hemorrhage 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Microsatellite Instability 01/2019
1	Turcot syndrome 01/2019
1	Diarrhea 01/2015
1	Hypertension (High Blood Pressure) 01/2015
1	Neutropenia 01/2015
1	Endometrial Neoplasms (Endometrial Cancer) 12/2001
1	Breast Carcinoma In Situ 12/2001
1	Carcinoma (Carcinomatosis) 03/2000
1	Rectal Neoplasms (Rectal Cancer) 03/2000
1	Ductal Carcinoma 01/2000

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 12/2001 - 01/2001
6	Tamoxifen FDA LinkGeneric 12/2001 - 01/2001
3	Sodium Glutamate (Accent)IBA 01/2020 - 05/2011
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2001
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 12/2000
2	AnthracyclinesIBA 01/2021 - 12/2000
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 05/2011
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 02/2001
2	desintegron BIBA 05/2001 - 01/2001
2	Methotrexate (Mexate)FDA LinkGeneric 02/2001 - 01/2001
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	veliparibIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	PlatinumIBA 01/2021
1	human ERBB2 proteinIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	taxaneIBA 01/2021
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2015
1	Hormones (Hormone)IBA 01/2015
1	pazopanib FDA Link 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 05/2011
1	Cytotoxins (Cytolysins)IBA 05/2011
1	Raloxifene Hydrochloride (Evista)FDA Link 12/2001
1	Cyclin D1IBA 06/2001
1	Biological ProductsIBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 01/2000
1	ras ProteinsIBA 01/2000
1	Proteins (Proteins, Gene)FDA Link 01/2000

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2001
5	Drug Therapy (Chemotherapy) 02/2001 - 03/2000
4	Neoadjuvant Therapy 01/2022 - 10/2001
4	Segmental Mastectomy (Lumpectomy) 08/2001 - 01/2001
3	Radiotherapy 08/2001 - 03/2000
3	Adjuvant Chemotherapy 02/2001 - 03/2000